dibucaine hydrochloride
UkraineDrugs containing this active substance
-
The preparation is used for the local treatment of acute inflammations of the oral cavity and throat, such as gingivitis, stomatitis, tonsillitis, laryngitis, and pharyngitis. It is also recommended for halitosis (bad breath), candidiasis (thrush), and during the postoperative period following tooth or tonsil extraction.
Form: tablets, chewable
Active substance Dosage decamethonium chloride 0.25 mg dibucaine hydrochloride 0.03 mg ATC: R02A
Manufacturer: Interkhim Limited Liability Partnership
-
The drug is used for the local treatment of acute inflammations of the oral cavity and throat, such as gingivitis, stomatitis, tonsillitis, laryngitis, and pharyngitis. It is also recommended for bad breath, candidiasis, and during the postoperative period following tooth extraction or tonsillectomy.
Form: tablets, chewable
Active substance Dosage decamethonium chloride 0.25 mg dibucaine hydrochloride 0.03 mg ATC: R02A
Manufacturer: Interkhim Limited Liability Partnership
-
The preparation is used for the local treatment of acute inflammations of the oral cavity and throat, such as gingivitis, stomatitis, tonsillitis, laryngitis, and pharyngitis. It is also recommended for halitosis (bad breath), candidiasis, and during the postoperative period following tooth extraction or tonsillectomy.
Form: tablets, chewable
Active substance Dosage decamethonium chloride 0.25 mg dibucaine hydrochloride 0.03 mg ATC: R02A
Manufacturer: Interkhim Limited Liability Partnership
-
The drug is used for the local treatment of acute inflammations of the oral cavity and throat, such as gingivitis, stomatitis, tonsillitis, laryngitis, and pharyngitis. It is also recommended for halitosis (bad breath), candidiasis, and during the postoperative period following tooth or tonsil removal.
Form: tablets, chewable
Active substance Dosage decamethonium chloride 0.25 mg dibucaine hydrochloride 0.03 mg ATC: R02A